Sequenom Faces Slew Of Shareholder Suits
Proposed securities class actions are continuing to pile up against Sequenom Inc. and its executives over allegedly overhyped and fraudulent statements the genetic analysis company made regarding a prenatal test it...To view the full article, register now.
Already a subscriber? Click here to view full article